Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001323255-25-000017
Filing Date
2025-05-14
Accepted
2025-05-14 16:34:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11508
2 ex1.htm EX-1 7332
  Complete submission text file 0001323255-25-000017.txt   20716
Mailing Address 5 PARAGON DRIVE MONTVALE NJ 07645
Business Address 5 PARAGON DRIVE MONTVALE NJ 07645 (845) 326-5600
BALCHEM CORP (Subject) CIK: 0000009326 (see all company filings)

EIN.: 132578432 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-39235 | Film No.: 25946391
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)

Mailing Address 666 THIRD AVENUE 2ND FLOOR NEW YORK NY 10017
Business Address 666 THIRD AVENUE 2ND FLOOR NEW YORK NY 10017 (917) 368-3500
APG Asset Management US Inc. (Filed by) CIK: 0001323255 (see all company filings)

EIN.: 061285941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A